SCHEMBL5994347

SCHEMBL5994347

Cc1cc(C)c(C(=O)P(=O)(CC(C)C)C(=O)c2c(C(F)(F)F)cccc2C(F)(F)F)c(C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 1/20 0.40
KCNK3 O14649 1/20 0.36
KCNK9 Q9NPC2 1/20 0.36
ALDH1A1 P00352 5/20 0.35
NPSR1 Q6W5P4 4/20 0.35
HPGD P15428 4/20 0.35
ALOX12 P18054 3/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 3/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2C19 P33261 2/20 0.34
MEN1 O00255 2/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
TP53 P04637 1/20 0.34
CTSS P25774 4/20 0.34
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5993896 0.91 CTSS (0.36) KCNK3KCNK9ALDH1A1NPSR1HPGD
SCHEMBL5995585 0.90 NPSR1 (0.35) LMNASMN1; SMN2HTTKCNK3KCNK9
SCHEMBL5996087 0.87 LMNA (0.37) LMNASMN1; SMN2HTTKCNK3KCNK9
SCHEMBL5994372 0.86 LMNA (0.42) LMNASMN1; SMN2HTTKCNK3KCNK9
SCHEMBL5995419 0.85 KMT2A (0.37) LMNASMN1; SMN2ALDH1A1NPSR1HPGD
SCHEMBL275128 0.84 KMT2A (0.38) LMNASMN1; SMN2ALDH1A1NPSR1HPGD
SCHEMBL5997714 0.81 LMNA (0.39) LMNASMN1; SMN2HTTKCNK3KCNK9
SCHEMBL5995376 0.81 LMNA (0.39) LMNASMN1; SMN2HTTKCNK3KCNK9
SCHEMBL5995387 0.81 KMT2A (0.40) LMNASMN1; SMN2KCNK3KCNK9ALDH1A1
SCHEMBL5994972 0.81 KMT2A (0.37) LMNASMN1; SMN2HTTALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7026017-B2 Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation CIBA SPECIALTY CHEMICALS CORPORATION (US) 2006-04-11 US disclosed
US-6969733-B2 Photoinitiators CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-11-29 US disclosed
US-6737549-B2 PHOTOINITIATORS FOR ACRYLATE COATINGS CIBA SPECIALTY CHEMICALS CORPORATION 2004-05-18 US disclosed
US-20030139485-A1 Photoinitiators WOLF JEAN-PIERRE (CH) 2003-07-24 US disclosed
US-20030130370-A1 Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation WOLF JEAN-PIERRE (CH) 2003-07-10 US disclosed
US-20020026049-A1 Photoinitiators for acrylate coatings CIBA SPECIALTY CHEMICALS CORP. 2002-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139485-A1 Photoinitiators DHCR24, NR1I3, CBR1 LMNA 763/4885SMN1; SMN2 3940/4885HTT 2638/4885
US-20030130370-A1 Photoinitiators for acrylic esters; reacting an acyl halide with a metal benzoyl phosphine; cable coatings, screen printing stencils, resist materials, colour filters, electrical encapsulation SMARCC1, ARPC5L, DHCR24 LMNA 975/4885SMN1; SMN2 1663/4885HTT 2818/4885
US-20020026049-A1 Photoinitiators for acrylate coatings DHCR24, NR5A1, NR2C2 LMNA 848/4885SMN1; SMN2 4099/4885HTT 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.